China National Biotec Group Company Ltd (CNBG) has announced a strategic collaboration with the University of Macau, marking a significant step in the biotech sector. The partnership, formalized with a signing ceremony at the Guangdong-Macao in-depth cooperation zone in Hengqin, aims to leverage the university’s cutting-edge research capabilities and CNBG’s industrial expertise to foster a comprehensive collaboration in the realms of scientific and technological innovation, talent development, and the commercialization of research outcomes. While financial specifics of the agreement were not disclosed, the joint laboratory is poised to become a pivotal force in driving innovation and advancing biotechnological applications.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
